GE Healthcare Invests in Future of Healthcare with 3D Printing, Robotic Surgery and Virtual Patient Monitoring Collaborations

Chicago, US – December 1, 2019 – GE Healthcare today announced its investments in and collaborations with Formlabs, CMR Surgical Ltd. and Decisio Health, companies specializing in 3D printing, surgical robotics and virtual care monitoring respectively. When paired with GE Healthcare’s diagnostic expertise and global scale, these three novel healthcare technologies will help expand clinical... Read more

GE Healthcare’s New Imaging Tech and Intelligent Apps Unveiled at #RSNA19 will Deliver Hundreds of Millions in Cost Savings and Provider Productivity

CHICAGO– December 1, 2019 – GE Healthcare today launched more than 30 new, imaging intelligent applications and smart devices designed to drive efficiency in radiology departments, aiming to double productivity and cost savings for systems by 2025. For healthcare executives, the new offerings help systems to save costs, improve technology utilization, and increase patient volumes.... Read more

GE Healthcare’s New Imaging Tech and Intelligent Apps Unveiled at #RSNA19 will Deliver Hundreds of Millions in Cost Savings and Provider Productivity

CHICAGO– December 1, 2019 – GE Healthcare today launched more than 30 new, imaging intelligent applications and smart devices designed to drive efficiency in radiology departments, aiming to double productivity and cost savings for systems by 2025. For healthcare executives, the new offerings help systems to save costs, improve technology utilization, and increase patient volumes.... Read more

GE Healthcare’s New Imaging Tech and Intelligent Apps Unveiled at #RSNA19 will Deliver Hundreds of Millions in Cost Savings and Provider Productivity

CHICAGO– December 1, 2019 – GE Healthcare today launched more than 30 new, imaging intelligent applications and smart devices designed to drive efficiency in radiology departments, aiming to double productivity and cost savings for systems by 2025. For healthcare executives, the new offerings help systems to save costs, improve technology utilization, and increase patient volumes.... Read more

Industry-First Innovation: GE Healthcare Unveils Novel Contrast-Enhanced Mammography Solution for Biopsy

Chicago – November 30, 2019 – To help empower clinicians and patients in their fight against breast cancer, GE Healthcare today introduced Serena Bright™*, the healthcare industry’s first contrast-enhanced mammography solution for biopsy.  Interventional and biopsy procedures are a necessary step in most breast cancer diagnoses. Previously, for lesions not seen on mammography or ultrasound,... Read more

GE Healthcare Expands Intelligent Health Ecosystem with Launch of Edison Developer Program to Ease AI Adoption for Providers

Holistic developer program provides deep technology integration in a secure platform; flexibly deploys in the cloud, at the edge or on device New Edison-powered smart devices and intelligent applications simplify workflows, drive efficiency and improve clinical outcomes  CHICAGO – NOVEMBER 26, https://www.genewsroom.com/press-releases/ge-healthcare-expands-intelligent-health-ecosystem-launch-edison-developer-program Read more

GE Healthcare Launches Edison Datalogue to Help Health Systems Break Down Siloes and Improve the Care Experience

CHICAGO – NOVEMBER 7, 2019 – GE Healthcare today launched Edison™ Datalogue™, a new enterprise data management solution, aimed at connecting data systems, devices, applications and clinicians to give health systems a more holistic view of their data, ultimately to help improve clinical and financial outcomes. The new offering combines GE Healthcare’s vendor neutral archive... Read more

GE Healthcare Life Sciences and Akeso Pharmaceuticals to speed up novel therapy manufacturing in China

GE Healthcare Life Sciences will supply Akeso Pharmaceuticals with the FlexFactory™ platform to accelerate the production of antibody drugs in the Guangzhou region Expected to be operational by end of 2020 and create up to 150 jobs upon opening. November 6, 2019 – Uppsala, Sweden and Guangzhou, China – Akeso Pharmaceuticals, a biotech company specializing... Read more

GE Healthcare announces U.S. FDA approval of macrocyclic MRI contrast agent Clariscan™ (gadoterate meglumine) injection for intravenous use

Clariscan, approved in more than 55 countries globally with over four million patient doses shipped, is now FDA-approved in the U.S. Expands the GE Healthcare portfolio of contrast media products  Chalfont St Giles, UK – November 4 2019 – The U.S. Food and Drug Administration (FDA) has approved Clariscan™, a macrocyclic, ionic, gadolinium-based, MRI contrast... Read more